Tech & Software

Investors in Ionis Pharmaceuticals experienced a surprising market reaction following the long-awaited FDA approval of Dawnzera. Instead of triggering a...

Beyond Air reported impressive first-quarter 2026 financial results, demonstrating both significant growth and ongoing challenges. The medical technology company achieved...

Forestar Group Inc. presents investors with a complex investment case as institutional positioning shifts, analyst sentiment remains positive, and recent...

As the educational technology sector navigates significant challenges, Nerdy Inc. is making a substantial strategic pivot toward artificial intelligence. The...

A fascinating divergence is unfolding for asset manager T. Rowe Price, where a technically-driven stock surge is clashing with a...

Shares of financial technology provider SurgePays are sending conflicting signals to the market. While the stock has recently achieved a...

Tencent Music Entertainment has reinforced its commitment to the live events sector by extending a key strategic partnership. The company's...

While numerous biotech equities continue to struggle in weak markets, Arcus Biosciences is demonstrating a notable trend: major institutional investors...

Oric Pharmaceuticals Inc is entering a pivotal period, with a series of key investor conferences scheduled for September designed to...

As global demand for dependable renewable energy intensifies, Ormat Technologies is making significant strides to solidify its position as a...